-+ 0.00%
-+ 0.00%
-+ 0.00%

WuXi Biologics wins BioPharma APAC spot on 2026 sustainable biopharma list

PUBT·08/18/2026 07:05:14
Listen to the news
WuXi Biologics wins BioPharma APAC spot on 2026 sustainable biopharma list
  • WuXi Biologics was named to BioPharma APAC’s “Top 26” sustainable biopharma companies list for 2026.
  • Recognition cited its Green CRDMO program, framed as integrating sustainability into R&D, development, manufacturing, operations.
  • Targets validated by the Science Based Targets initiative, including a net-zero value-chain emissions goal by 2050.
  • Manufacturing claims include up to 70% water savings using single-use technology versus stainless steel; up to 80% lower product carbon footprint with WuXiUI plus SUT.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608180304PR_NEWS_USPR_____CN28458) on August 18, 2026, and is solely responsible for the information contained therein.